LH

Labcorp to Release Q3 2024 Financial Results

Labcorp (NYSE: LH) announced that it will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results.

Labcorp reported that in the third quarter of 2024, it served clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world.

Labcorp's financial results for the third quarter of 2024 will be available on the Labcorp Investor Relations website. The call will be webcast live on the same website. A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until September 10, 2025. The market has reacted to these announcements by moving the company's shares -0.7% to a price of $218.99. For the full picture, make sure to review Labcorp's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS